Some sense in the biomedical IP mess: "NIH intervenes in Alzheimer's mouse lawsuit"

classic Classic list List threaded Threaded
2 messages Options
Reply | Threaded
Open this post in threaded view
|

Some sense in the biomedical IP mess: "NIH intervenes in Alzheimer's mouse lawsuit"

Glen Newton
http://blogs.nature.com/news/2011/06/nih_intervenes_in_alzheimers_m.html?utm_source=feedburner&utm_medium=twitter&utm_campaign=Feed%3A+news%2Frss%2Fthe_great_beyond+%28The+Great+Beyond+-+Blog+Posts%29&WT.mc_id=TWT_NatureNews

"The US National Institutes of Health (NIH) has leapt to the rescue of
a laboratory that was sued for distributing mouse models to
researchers.
Today, NIH director Francis Collins sent a letter to the Jackson
Laboratory in Bar Harbor, Maine, granting NIH's "authorization and
consent" for the lab to distribute 22 mouse models of Alzheimer's
disease. This move shields the Jackson Lab from a 2010 lawsuit over a
patent that covers a genetic mutation carried by the mice."

Does anyone know if this is a power that the Government of Canada can
also exercise? And if yes, any examples?

-Glen

--

-

Reply | Threaded
Open this post in threaded view
|

Re: Some sense in the biomedical IP mess: "NIH intervenes in Alzheimer's mouse lawsuit"

Kent Mewhort
Glen, this is actually more of a compulsory licensing regime than any type of exception to patent protections.  The "authorization and consent" only moves the liability over to the government and limits liability.  That is, the patent holder is still entitled to compensation, but is only permitted to sue the U.S. government, not Jackson Laboratory.  They can also only get "reasonable" compensation from the government.

We have similar clauses in Canada.  The Patent Commissioner may authorize any government to use a patented invention, paying only "adequate" renumeration.  The Canadian version of this mechanism doesn't explicitly shield third parties, but the same protection likely applies as long as the third party acts as the government's agent.

I've never heard of this clause actually being used (though it quite possibly has been).  There's actually quite a few exceptions and public-good provisions that exist in patent systems -- ie. the international agreement, TRIPS, even allows governments to provide exceptions for urgent situtations and even "public non-commercial use".  Unfortunately, there's a lot of pressures from commercial industries for government to not use these exceptions....

------------------------------
Kent Mewhort ([hidden email])



On Mon, Jun 20, 2011 at 2:03 PM, Glen Newton <[hidden email]> wrote:
http://blogs.nature.com/news/2011/06/nih_intervenes_in_alzheimers_m.html?utm_source=feedburner&utm_medium=twitter&utm_campaign=Feed%3A+news%2Frss%2Fthe_great_beyond+%28The+Great+Beyond+-+Blog+Posts%29&WT.mc_id=TWT_NatureNews

"The US National Institutes of Health (NIH) has leapt to the rescue of
a laboratory that was sued for distributing mouse models to
researchers.
Today, NIH director Francis Collins sent a letter to the Jackson
Laboratory in Bar Harbor, Maine, granting NIH's "authorization and
consent" for the lab to distribute 22 mouse models of Alzheimer's
disease. This move shields the Jackson Lab from a 2010 lawsuit over a
patent that covers a genetic mutation carried by the mice."

Does anyone know if this is a power that the Government of Canada can
also exercise? And if yes, any examples?

-Glen

--

-
_______________________________________________
CivicAccess-discuss mailing list
[hidden email]
http://lists.pwd.ca/mailman/listinfo/civicaccess-discuss